AZR
Azora Therapeutics
AZR | NASDAQ
Chart Builder DCF Calculator
$3.81
-$0.28 (-6.85%)
At close: Nov 16, 2026, 4:00 PM ET

Azora Therapeutics Company Profile

Company profile explained

Company Profile

Azora Therapeutics is a biopharmaceutical company developing treatments for serious inflammatory diseases. Its lead program, AT177, is an oral, colon-targeted aryl hydrocarbon receptor agonist in development for ulcerative colitis.

Key Executives

Name Position
Julie Saiki Co-Founder, Treasurer, Secretary & Director

Latest SEC Filings

No SEC filings available
View All SEC Filings ➞
Azora Therapeutics
AZR
Country United States
IPO Date Jul 27, 2018
Industry Medical - Pharmaceuticals
Sector Healthcare
Employees 6
CEO Cary J. Claiborne

Contact Details

4267 Valley Meadow Road Encino, California 91436 United States

Stock Details

Ticker Symbol AZR
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code 0001513525
CUSIP Number 054800107
ISIN Number US0548001074
SIC Code n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.